EFFICACY AND SAFETY OF IXEKIZLTMAB VERSUS ADALIMUMAB (SPIRIT-H2H) WITH AND WITHOLIT CONCOMITANT CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIMIEUMATIC DRUGS (DMARD) IN BIOLOGIC DMARD-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS: 52-WEEK RESULTS
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要